The systemic inflammatory response following coronary bypass is initiated by complement activation and release of pro-inflammatory C)10-kines due to the use of extracorporeal circulation. Heart surgery without coronary bypass may reduce the risk for such complication. Twenty-one patients submitted for elective coronary bypass surgery were included in a prospective and randomised study. Eight patients were operated with, and thirteen without coronary bypass. Plasma levels of neopterin, complement anaphy-Iatoxin 3a, interleukin-8 (LL-8) and tumour necrosis factor-a. (TNF-a.) were measured before and during, two and 24 hours after surgery. The number of coronary bypass grafts did not differ between the two groups. Plasma neopterin did not differ significantly between the two studied groups. In the coronary bypass group the C3a levels were higher during the operation (2509 ± 597 vs591 ± 99ng/mL, p <0 .001) and two hours after surgery (824 ± 152 vs 466 ± 79 ng/ml; p <0 .05): There were
Elevated serum neopterin is characteristic of cardiomyopathy of various genesis, AIDS, organ rejection and other diseases that come along with an activation of the cellular immune system. In patients with chronic heart failure and rheumatic fever a correlation between the neopterin concentrations and the severity of disease was found. This implies that neopterin is not only a prognostic marker for the severity and outcome of disease but that it could be involved in the pathogenesis of cardiac symptoms and disease. Neopterin was shown to be an activator of inducible nitric oxide synthase (iNOS) and NO-production in vascular smooth muscle cells. NO is a free radical with negative inotropic, cytotoxic and prooxidant properties when produced in pathologically high (submillimolar) concentrations. Neopterin was also shown to be a modulator of oxidative stress. This study was performed to clarifY a hypothetical causal role of neopterin in cardiac pathology and a possible connection between neopterin and NO as prooxidant substances acting on cardiac function. The method used was a Langendorff-preparation for the perfusion of the isolated heart. 79 male SpragueDawley rats with an average weight of 305g (275-340g) were anesthetized with Nembutal (40-60 mglkg iv). The hearts were isolated by thoracotomy, arranged in the Langendorff-apparatus and kept alive by perfusion via the aorta with a modified Krebs-Henseleit buffer. Left ventricular pressure, coronary flow, contractility and heart rate were measured for an hour. The different groups were treated with either the NO-donor NOC-15, a non specific inhibitor of NOS (LNMMA), a specific inhibitor of iNOS (Aminoguanidine), a prooxidant substance (recombinant tumour necrosis factor-a. T~-F) or an inhibitor of oxidative stress (N-acetylcysteineINAC), with and without neopterin. The data was evaluated by a multivariance analysis with SPSS 8.0. A correlation analysis served to distinguish £1ow-dependent from flow-independent effects of neopterin on myocardial function. A significant decrease of coronary flow by 36<)'0 (p<0.05) and of myocardial contractility by 2-:'% (p<0.05) was observed upon perfusion with neoptcrin The coperfusion with neopterin and NAC resulted in a stabilisation of coronary flow at normal values, whereas NOC, LNMMA, aminoguanidine and TNF did not interfere significantly with neopterin. According to the correlation analysis the decrease of contractility is to 69% due to flow-dependent, to 31 % due to 00\\-independent mechanisms, including effects mediated b~ neopterin (R=O.69). Since the free radical scavenger NAC was able to stabilise coronary flow the vasoconstrictive effects of neopterin on coronary vessels are most probably due to an increase of oxidative stress by neopterin. The exact mechanism remains unclear, however, a rapid inactivation of NO by neopterin-induced free o~,:ygen radicals is likely, especially in the presence of superoxide anion, O 2 -. O 2 - and NO react to form the highly toxic peroxynitrite (ONOO-), neopterin may facilitate this reaction, The effects observed in this study were not due to the activation of iNOS and NOproduction by neopterin. However, it is likely that damage to coronary vessels and myocardium may be triggered by neopterin via the induction of the iNOS and the production of cytotoxic concentrations of NO when hearts are permanently exposed to high concentrations of neopterin as it happens in chronic disease states such as chronic heart failure. no significant differences regarding IL-8 or TNF-a. between the groups. IL-8 and TNF -a. were higher during and after surgery compared to the preoperative levels. Coronary bypass without the use of extracorporeal circulation reduces the degree of complement activation but does not significantly alter neopterin and proinflammatory cytokine release.
Tetrahydrobiopterin deficiency without hyperphenylalaninaemia
Blau N, Bonafe L, ThOny B Division of Clinical Chemistry and Biochemistry, University Children's Hospital, Zurich, Switzerland Historically, defects of BJ-l4 metabolism have been identified during follow up studies designed to establish the cause of hyperphenylalaninaemia (HP A) found either during newborn screening or at a later date in a child with neurological signs of unclear origin. It is now apparent that HP A is not a prerequisite for onset of clinical symptoms where there is defective BlL metabolism. Autosomal dominantly inherited, and compound heterozygote PteridineslVol I UNo. 1 forms of GTP cyclohydrolase I (GTPCH) deficienc:-(Dopa-responsive dystonia, DRD), together with an apparent CNS-Iocalised form of DHPR deficiency ha\ c recently been recognised, none of which have been associated with HPA in infancy. Until recently a presumed diagnosis of DRD was generally achieved by careful examination of th-:: clinical phenotype followed by a trial of L-Dopa Confirmation of the diagnosis in a patient respondJ n ~ to L-Dopa requires, however, follow-up tests as tyroSlf). ; ; o hydroxylase deficiency and 6-pyrmo: 1-tetrahydropterin synthase (PTPS) deficiency ca:-present with similar clinical phenotypes and there :lI': many types of dystonia and other movement disorders that can respond to some degree to L-Do~~ Concentrations of BJ-l4 and neopterin in CSF are 10\\ ;n dominantly inheded GTPCH deficiency and genera; J:. there is a reduced level of HV A. Definitive diagnosl S :s achieved by detection of mutations in the GTPCH gen-:: however, there is no common mutation, making thiS .' .. tedious process. An oral phenylalanine loading test (100 mg/kg) hz.~ also been developed to aid in diagnosis. The t~, exposes the partial deficiency of BEL in the liver, whl.: r manifests as an inability to convert phenyl-alanine :: tyrosine at a normal rate leading to c!e\ateC phenylalanine to tyrosine ratios in plasma for a penod of at least six hours following the load. Abnonn2.: phenylalanine / tyrosine profiles can also be seen i ::-. other conditions like heterozygous phenylketonuria Measurement of GTPCH activity in ph)'1ohaem-agglutinin stimulated lymphocytes can demonstral" decreased GTPCH activity but some nonnal cells 31" not activated by this process, making for a higr; likelihood of a false positive result. To determine the utility of cultured skin fibroblasts fO f the differential diagnosis of DRD and atypical PKl variants. The authors examined neopterin and biopten n production in cytokines (interferon-y and tumour necrosis factor-a.)-stimulated cultures skin fibroblasts in 5 patient with DRD, three patients with autosoma! recessive GTPCH deficiency, six patients with PTPS deficiency, and one patient with dihydropteridine reductase (DHPR) deficiency. In the same fibroblast GTPCH, PTPS, DHPR, and sepiapterin reductase was measured. Normal values were established for 22 agematched infants with normal neurologic development (control group), three foetal samples, and 11 amniotic fluid samples.
Prolonged survival of murine cardiac allografts b)· treatment with the 4-amino analogue of tetrahydrobiopterin The 4-amino analogue of tetrahydrobiopterin (H4-aminobiopterin) is a novel pterin-based inhibitor of NO synthases. ~-aminobiopterin has been developed to inhibit potential recycling reactions inside the active NO synthase dimer. All three isoforms of NO synthase are inhibited by micromolar concentrations of the compound. In tissue culture, the compound showed a remarkable selectivity for the inducible isoform of NO synthase (iNOS). Since NO synthase and nitric oxide is known to be induced during allograft rejection and may have a deleterious effect on graft function and survival, we tested this novel compound for its efficacy in suppressing allograft rejection. 8-10 week old, male C57BLIl0 (H-2b) donor hearts were heterotopically transplanted into 12 week old, male C3HJHe (H-2k) recipients utilising a modified cuff technique for revascularisation. During the first postoperative seven days recipients were treated with H 4 H4-aminobiopterin applied every 8 hours (survival 14.8 +/-2.1 days) produced results comparable to high dose cyclosporin A treatment (survival 15.0 +/-1.9 days) p < 0.025 . Attenuation of allograft rejection by H 4 -aminobiopterin was also seen on histological sections of the hearts at day 8 post transplantation. Surprisingly, neither plasma levels of nitrite plus nitrate nor expression of iNOS, IFNy, and TNF-cx. was altered by the dose regimen effective in improving graft survival. H4-Aminobiopterin is a new agent remarkably effective in improving murine cardiac allograft survival. The mechanism of action of this new NO synthase inhibitor, however, remains to be determined. Thus, more sophisticated approaches like cDNA ex-pression arrays or subtractive libraries are under current investigation. Iron chelation therapy for treatment of severe Plasmodium talciparum infection has previously been shown to exert beneficial effects on the clinical course of cerebral malaria in children. Methods: Based on in-vitro data demonstrating that the iron chelator desferrioxamine stimulates the transcriptional expression of inducible nitric oxide synthase (iNOS) and the formation of NO, a labile radical which is involved in anti-plasmodial activity of macrophages, we now investigated whether the in vivo effect of desferrioxamine on clearance of plasmodia can be either referred to stimulation of NO formation by the drug or to limitation of iron availability to the parasite. For this purpose we set up a co-culture model consisting of murine macrophages which produce high amounts of NO and of Plasmodium (alciparum infected human erythrocytes which were separated from each other by 0.44 J.1M.
Regulatory interactions between iron and nitric oxide metabolism for immune defence against
Results: Treatment of murine macrophages (RA W 264.7) with IFN-yILPS resulted in strong increase of NO fomlation and a decreased survival of plasmodia within co-cultured human erythrocytes. The addition of desferrioxamine prior to cytokine stimulation increased both, NO formation and parasite killing, while the drug had no effect on the survival of PI. ( Interferon-y is capable of inducing activation of various enzymes in target cells including GTPcyclohydrolase I and indoleamine (2,3)-dioxygenase. In most cells activation of GTPcyclohydrolasc I leads to increased production of 5,6,7,8-tetrahydrobiopterin, a necessary cofactor for certain monoxygenases and nitric oxide synthases. In contrast, due to deficiency of pyruvoyltetrahydropterin synthase in human monocytes I macrophages, activation of GTP-cyc1o-hydrolase I results in overwhelming production of neopterin and 7,8-dihydroneopterin at the expense of 5,6,7,8-tetrahydrobiopterin. In agreement, diseases which are associated with cell-mediated (= Th-l type) immune activation are characterised by increased neoplerin concentrations in body fluids . Activation of indoleamine (2,3)-dioxygenase, the key enzyme of cytokinc-induced degradation of tryptophan, leads to the formation fo several tryptophan catabolites such as kynurenine, anthranilic acid and quinolinic acid which are accumulating in body fluids of patients with increased endogenous formation of interfcron-y or cytokine administration. Unlike neopterin formation, the production of tryptophan catabolites is by no means specific for activated monocytes / macrophages, but both, increased formation of neopterin and, C.g. , kynurenine is a typical result of cellular immune response and formation of interferon-yo From earlier studies we have concluded that endogenous formation of interferon-y is associated with the development of immunodeficiency (1), and it seems that the modulation of oxidative stress by neopterin derivatives could play a role in its pathogenesis, driving T -cells into apoptosis. Recent studies (2) shed some new light on tryptophan catabolism to be also involved in the development of immunodeficiency and T-cell tolerance. All together, the data imply that the induction of enzymatic reactions in immunocompetent cells by interferon-y is directed to slow down immune response achieving homeostasis. A process which is certainly beneficial in acute immune response, when immune response has to be forced to come to an end when the activating agent has been successfully destroyed. However, it may have serious consequences in situations whenever immune activation becomes chronic as, e.g., in certain virus infections or malignancy. In these cases the downregulatory cascades may hinder successful immune reaction. It may contribute to the development of Physarum polycephalum, a myxomycete living either as multi-nucleated giant cell (macro-plasmodium) with naturally synchronous mitosis or differentiating into diploid encysted forms (sclerotia, spherules) or haploid spores in order to form resistant stages surviving . adverse environmental conditions and also to undergo genetic recombination in the case of spore formation, has become a model system in cell biology. In previous work we have shown by measuring various metabolites and enzyme activities that Phvsarum fomls 5,6;7,8-tetrahydrobiopterin and 6-hydroxymethyl-7,8-dihydropterin, an intermediate offolic acid biosynthesis (1). Here, we studied GTP cyclohydrolase I expression in more detail. A cDNA probe was generated by PCR. mRNA expression, as determined by Northern blotting, as well as GTP cyclohydrolase I activity and intracellular biopterin levels remained unchanged during cell cycle whereas they are down-regulated during spherulation (within 12 hours) and sporulation (within 96 hours). Cloning GTP cyclohydrolase I from a Physarum cDNA library identified two mRNAs encoding for proteins of 228 (25 .7 kDa) amino acids and 195 (22.1 kDa) amino acids. The amino acid sequence of the two proteins is identical despite their C-termini after position 186. Interestingly, this position is highly homologous to that found for various splice variants of human GTP cyclohydrolase I. In this case, the position is identical to the border of exons 5 and 6. It remains to be seen whether this applies also to Physarum . Recombinant expression of the two Physarum mRNAs in baculovirus-infected insect cells (Sf9) showed that only the 228 amino acids protein was catalytically active. Among GTP cyclohydrolase I amino acid sequences from various species, identity of the Physarum 228 aa protein is highest with the one of Dictyostelium discoideum (65.75%) .
( The aim of the study was to determine if neopterin and interleukin-(IL)-6 and 8 are released in orthotopic liver transplantation. Twenty consecutive patients undergoing orthotopic liver transplantation were studied and they were divided into two groups; Group 1) Duration of cold ischaemia longer than 12 (n = 11) and Group 2) Duration cold ischaemia shorter than 12 hours (n = 9): Blood samples for neopterin and lL-6 and lL-8 determinations were drawn preoperatively, 1 min before perfusion of the grafted liver and 120 minutes after the start of perfusion of the grafted liver. Preoperatively there were no significant differences regarding neopterin and IL-6 and IL-8 between the two studied groups. I ncreased concentrations of neopterin, IL-6 and lL-8 were found 120 minutes after revascularisation of the transplanted liver in both groups. In patients receiving a liver with a cold ischaemic time longer than 12 hours (Group 1) the concentration of neopterin and IL-8 were higher (p <0.05) compared to what was found in patients receiving a liver with cl cold ischaemia time shorter than 12 hours (Group .2) Group 1 required a higher volume of erythrocyte ,:oncentration and fresh frozen plasma during the operation (p <0.05). This study indicates that plasma levels of neopterin and pro-inflammatory 010kines are release during orthotopic liver transplantation and that lL-8 is influenced by the duration of the cold ischaemic time.
Cerebrospinal fluid neopterin concentration is associated with markers of neuronal destruction in AIDS High levels of neopterin are a common finding in situations associated with an increased activity of the cellular immune system. Apart from being a clinical marker for these conditions, evidence suggests that neopterin exhibits distinct biochemical functions via interactions with cellular redox mechanisms and promotion of oxidative stress. Therefore, one may speculate that neopterin plays a role as a modulator during host defence reactions. It has been demonstrated . that oxidative stress inhibits intracellular Ca 2 + transients in various cell types. Cytoplasmic Ca 2 + increase is generally considered to be an important second messenger for the exocytosis of surfactant proteins in type II alveolar epithelial cells. Thus, disturbances of cellular Ca 2 + homeostasis might be involved in pulmonary dysfunctions. In the present study, we investigated the effects of neopterin on A TPinduced Ca 2 + transients in a type II -like alveolar epithelial cell line (L2). L2 cells were incubated with 4 J1M Fura-2 for 15 min, mounted in a perfusion chamber and investigated at 37°C in permanent perfusion. Fura-2 fluorescence was visualised by an image analysis system, pictures were digitised at a frequency of 0.1 Hz. In a first set of experiments, the cells were exposed for 100 sec to A TP (1 !J,M), a potent stimulator of surfactant secretion and Ca Between 1992 and 1994, 973 HIV-l seropositi\e patients attending an out-patient clinic at the University Teaching Hospital in Lusaka were enrolled into a natural history cohort to study HIV progression in Africa. Forty-three percent of the patients were female . the mean age was 30.7 years. By the end of July 1999. 3005 person-years of follow-up were analysed, the median follow-up was 2.8 years. 281 patients (29%) had died, the overall death rate was 9.4 per 100 personyears. The death rate was significantly higher in females than in males (10.1 vs 8.8 P <0.05). The median neopterin level at recruitment was 15.3 nM. The death rate in patients with a baseline neopterin above 15 nmollL was 16.1, compared to only 3.2 in those with a baseline neopterin below 15 nmollL (rate ratio, adjusted for sex and age, 4.91; p <0.001). After 5 years, 57% of patients with high neopterin at recruitment had died, but only 13% of patients with low neopterin. In those who died, the median annual change in neopterin was significantly higher than in survivors (4.23 oM vs 0.87 oM; P <0 .001). CD4 count, total lymphocyte count, and haemoglobin were also predictors of death: the death rate in patients with a CD4 count above 200/111 was 2.8 per 100 person-years, compared to 13 .5 in patients with CD4 counts below 200 (adjusted rate ratio 4.61 , p <0.001). Patients with a total lymphocyte count below 1500/111 were more likely to die than patients with a higher lymphocyte count (adjusted rate ratio 1.85, p <0.01). Severe anaemia (haemoglobin <8 g/dL) was associated with a 6.55 fold increase in the death rate in comparison to patients with normal haemoglobin (34 .8 vs 4.9, P <0.001). The death rate in patients with mild anaemia was 11.9. All progression markers investigated were associated with death. Neopterin is at least as good a predictor of mortality as CD4 counts, and can be of particular value in settings where more expensive progression markers cannot be used.
Changes of neopterin, haemoglobin and body temperature in patients after orthopaedic surgery The results of retrospectively and prospectively randomised clinical trials on transfusion-associated Immunosuppression are conflicting, and at present I t is still unclear whether allogeneic blood transfusions per se and which amount of transfused allogeneic leukocytes are critical in order to cause clinically relevant immunosuppression. Evidence exists. that the combination of surgical trauma and additional allogeneic transfusions promotes a Th2-'\-pe immune response favouring antibody formation but subsequently suppressing Thl-type immune responses. Following activation with interferon-g the monocyte 1 macrophage system produces large amounts of neopterin, reflecting activation of the cellular immune system. However, increased serum neopterin concentrations are associated with decreased T-cell proliferative responses and are also seen in anaemia of chronic diseases. To clarify the impact of surgical trauma and allogeneic or autologous transfusion on the function of the macrophages system we investigated the .: hanges of serum neopterin, haemoglobin (Hb) and body temperature (Qe). Measurements were obtained preoperatively and on postoperative day 1 and 7 in 60 consecutive patients scheduled for elective orthopaedic surgery. Data of 50 patients remained for final analysis. Thirty of these patients received their preoperatively donated autologous buffy coat -depleted red cells (G I) while 20 patients received allogeneic buffy coatdepleted red cells (G2) only. The paired t-test and Spearman rank correlation were used for statistical analysis. A p-value <0.05 was considered statistically significant. Postoperative neopterin serum values increased in both groups. This increase was significant on postoperative day 1 in GI (day 0 vs day 1, p <0.001). Contrarily, in G2 neopterin serum concentrations increased continuously, peaking on day 7 (day I vs day 7, P = 0.01). In both groups Hb values showed a significant drop on postoperative day I, concomitant with an increase of body temperature. An inverse correlation of Hb and neopterin (N) was found, which was significant in GI on days I (HbO : NI , p = 0.01) and 7 (Hb7 : N7, p <0.05) and in G2 at baseline only (HbO : NO, P <0.01; Hb1 : NO, p <0.05). The present study shows a pattern of postoperative activation of the macrophages system in allogeneic recipients somewhat different than that in autologous recipients. It seems that allogeneic transfusion provokes a delayed and possibly sustained activation of the cellular immune system, which might lead to hyporesponsiveness. We also found an inverse relationship of haemoglobin and neopterin, which has been reported in patients with anaemia of chronic diseases. This was slightly more pronounced in autologous recipients and might be due to a decreased iron load associated with autologous transfusion. We therefore measured serum concentrations of neopterin, tryptophan and kynurenine, and calculated the kynurenine per tryptophan ratio as an estimate the activity of PteridinesIVol. 1111\0 I indoleamine 2,3 dioxygenase (IDO). We also determined the local concentration of neopterin in aqueous humour of the anterior chamber of eye obtained during cataract extraction surgery. We examined the samples from 31 cataract patients (mean age 75 years) -23 with PEX and 9 without PEX There were significant associations between the increase of neopterin and the degradation of tryptophan in all patients: neopterin correlated strongly with kynurenine concentrations in serum (rs = 0.456, P <0.005) and with the kynurenine per tryptophan ratio (rs = 0.501 , P <0.001). In patients with PEX we found out a positive correlation between neopterin concentrations in serum and in aqueous humour of the anterior chamber. Our preliminary data suggest that immune activation as indicated by increased neopterin concentration is associated with increased IDO activity in cataract patients. The finding of a positive correlation between serum and humour neopterin concentrations in PEX patients presents some further evidence for local immunological activation being involved in a possible pathogenetic mechanism of PEX Homocysteine and B-vitamins in dementia patients as a whole (n = 31), a significant correlation was found between MMSE and HCY (r = -0.43; P = 0.016), MMSE and folic acid (FA; r = 0.37, P <0.05) and between FA and HCY (r = -0.36, P <0.05). In 9 out of our 31 demented patients (29%), hyperhomocysteinaemia was found. These patients were treated with 50 mg vitamin B 1 , 50 mg vitamin B 6 , 5 mg FA, and 0.05 mg vitamin Bl2 (Beneuran compositum™ 1 tablet per day). Comparing HCY serum levels before and after four weeks of treatment, serum HCY levels had returned to normal in all patients, drastically decreasing from 17.3 +/-1. 9 to 10.7 +/-3.5 ~mol/L (t = -7.72; P <0.0001 paired t-test).
These data underline the hypothesis that hyperhomocysteinaemia as a risk factor for atherosclerosis, may also be of relevance in AD. Further, our data indicate that fortification of food with FA would be an additional therapeutic option in both, AD and YD. Long standing carbohydrate malabsorption syndromes such as fructose malabsorption and lactose malabsorption may lead to bacterial overgrowth of the terminal ileum. It was of interest to find out if distal small intestine bacterial overgrowth syndrome (SIBOS) goes along with systemic signs of inflammation, and if the metabolic activity of the overgrowing bacteria correlates with immunological markers such as neopterin. SIBOS is characterised by clinical symptoms such as Diarrhoea, weight loss, signs of malabsorption and abdominal discomfort like cramps and bloating that start within 30 min after ingestion of a mal absorbed meal, and it is defined as an abnormally high bacterial population in the upper gut, exceeding 10 5 organisms/ml (5 log colony forming unit CFU/ml). In Austria, blood donations are additionally screened for increased neopterin concentrations to reduce the risk of infectious diseases transmission. I n this study, we analysed the perfonnance and reproducibility of neopterin screening by ELISA (BRAHMS, Berlin) in a blood donation setting. A perfonnance control serum was prepared by our own and it was included in each test run. Expert' s report was perfonned by the Institute of Biostatistics (Prof. Dr. P61z, Linz) comparing data from the blood donation centres of Innsbruck and Linz in order to establish a common cut-off value (98 th percentile) for all blood donation centres in Austria. Evaluation of different procedures for the handling of the assay were evaluated and compared, and different ELISA systems for screening of mv -antibodies and HCV-antibodies were compared with the neopterin ELISA. Large variation between the lots of the neopterin ELISA were observed when comparing the perfonnance controls which caused problems to determine the 98 th percentile. An instability was noticed: results dropped under the mean value instead of spreading regularly. This fact was also observed in the Blood Donation Centre in Linz, Austria. The question arose whether different qualities of the assay lots were the reason for this problem or whether it is a loss of the neopterin content in the perfonnance control serum with time due to storage conditions. However, the perfonnance controls behaved rather differently: a time-dependent decrease was seen with the first serum, the second serum seemed more stable over the used lots although differences could be seen. The results observed at Linz were similar. In an earlier study, we evaluated different handling methods: a completely manual procedure (samples and test components), semi automated (samples manually, test components by Behring ELISA Processor II) and fully automated (samples with Hamilton Microlab AT plus, further process with Behring ELISA Processor III). All results were calculated from two different photometric readings and curve fittings. The manual and semi automated methods gave poorest, the automated method the best results of mean values over 4 plates (target value was 10.15 nmollL; 2 S.D. : 1.15 nmol/L). Intra-assay variation was clearly under 10% with the automated system and just slightly higher than by manual processing. Semi automated processing delivered poorest results (up to 14% variation). Interassay variation was best with the automated process. The variations of the neopterin ELISA were compared with the qualitative antibody tests for HIY and HCV. One unit of plasma (previously tested negative for all parameters and was meant to be used for transfusion) was used and neopterin concentrations, HCV -and HIV-antibodies were determined at the same time. The intra-assay variations for the neopterin and the Heyantibody tests were around 4% whereas a 17% variation was found for the mv -antibody test. Inter-assay variations were 4% for neopterin, 34% for the mvantibody ELISA and 44% for the HCY-antibody ELISA. Due to this irritating finding, the reproducibility of the mv -antibody and HCY -antibody PteridinesNol. Il1No. I ELISAs was examined, using a specimen which was previously tested borderline positive (in the cut-off range). With this specimen the intra-asssay variations were below 10%, 6% for the HIVantibody and 8% for the HCV -antibody test. We conclude from the data that further studies will be necessary to address the question whether the relatively poor reproducibility of the ncopterin ELISA (microplate version) is a general problem caused by, e.g., differing test lots or how much the decline of neopterin concentrations in the performance control serum contributes to this result. It is known that some samples may keep their neopterin concentration over a long period of time during deep-frozen storage, whereas others are more prone to laos the neopterin content steadily during storage. We recommend the use of a stable performance control semm provided by the manufacturer and to change to a "qualitative" ELISA for the use of screening blood donations. This would mean the use of one control semm with a concentration in the "cut off range" instead of 5 standards. Such a procedure would not make this a real qualitative assay. Qualitative ELiSAs are designed to find tmly positive and tmly negative samples far away from the cut off. Only few samples will lest in this region. Whereas for neopterin testing, many samples will be found in this cut off range.
Another possibility would be the implementation of the alpha-Mode, a curve-fitting used with Behring ELISA tests using only one control serum (e.g. Rubella antibody quantification).
Apoptosis induced by neopterin derivatives in rat PC12 cells Apoptosis is a naturally occurring form of cell death and plays an important role in neurodegeneration. In neurodegenerative diseases such as Parkinson's disease, amyotrophic lateral sclerosis and Alzheimer disease, increased production of neopterin derivatives, proinflammatori cytokines such as tumour necrosis factor-a (TNF-a) and reactive oxygen intermediates were observed. Microglial cell activation has been suggested to contribute to apoptosis in neurological disorders, and recently, neopterin and 7,8-dihydroneopterin were found to interfere with redox-sensitive intracellular signalling pathways, PteridinesIVol. lllNo. 1 and data implied a potential role of neopterinderivatives in oxidative stress-mediated apoptosis. In recent studies it was shown that 7,8-dihydroneopterin induced apoptosis in Jurkat cells and that reduced forms of pteridines mediated apoptosis in human neuronal NT2 cells. Based on these findings we investigated whether neopterin derivatives especially neopterin and 7,8-dihydro-neopterin could interfere with signal transduction pathways in pcn cells. Thus, PC l2 cells -non differentiated and differentiated -are presenting an interesting model for studying the impacts of neopterin derivatives on the loss of neurons in neurodegenerative diseases. Since this cell line has the ability to differentiate into sympathetic neurons by exposure to nerve growth factor-6 (NGF-6). Apoptosis was confirmed by measurement of the nuclear contents of fluoreSCing DNA by propidium iodide staining and analysis in the fluorescence activated cell sorter (F ACS). Neopterin is a marker of macrophage activation correlating with the degree of immune activation and clinical severity of diseases. In particular the anti-viral immune response, predominantly mediated by interferon gamma IFNy. is leading to a significant increase in neopterin concentrations, both in serum and urine. The underlying study was performed to investigate whether measurements of neopterin might (a) detect the anti-viral immune response associated with CMV infections; (b) reflect the clinical severity of the CMV infection; and (c) facilitate the clinical decision making to use antiviral drugs. In this retrospective study 16 patients showing both virological and clinical evidence of CMV infection were included. They received a renal allograft between 1987 and 1992. For all patients long-term data on the clinical course were available. Virologic evidence of CMV infection was defined if one or more of the following findings was noted: seroconversion with the appearance of anti-CMV IgM antibodies; a fourfold increase in preexisting anti-CMV IgG titers; detection of CMV antigens in infected cells; and/or isolation of the virus by culture of the urine. Clinical symptoms and signs were defined as the occurrence of fever, leukopenia, night sweating, and/or organ involvement like increase of transaminases or decrease of oxygen saturation. For analysis the patients were separated in those who received specific antiviral therapy with ganciclovir due to severe clinical CMV disease and those who did not receive ganciclovir. Neopterin measurements were performed daily during the stay on ward and on each single visit to the outpatient clinics. The neopterin values were calculated in relation either to serum or urine creatinine values (serum or urine neopterin J.lmol/mol creatinine) and determined by ELISA. In addition to the conventional CMV diagnostic tests stored plasma samples were measured with a CMV specific western blot. Recombinant his-tagged peptide fragments comprising immunoreactive epitopes and flanking regions of the viral tegument proteins pUL83 (pp65) and pUL32 (pp150) and the surface components gpUL55 (gB) and gpUL75 (gH) were used for detection of specific IgI\.1 in stored plasma samples by immunoblotting. In all patients serum amyloid A protein, serum transaminases, blood leukocytes, and body temperature were measured daily on ward and in the outpatient clinics. Lymphocyte surface markers and tests for further herpes viruses were measured twice weekly on ward and in the outpatient clinics. All together 16 patients were included in the study. The median period of postoperative observation was 1046 days. 11 of these patients suffered from severe CMV disease and were treated with ganciclovir (CMV disease group). The remaining 5 patients had clinical evidence of CMV infection but did not need additional ganciclovir therapy (CMV infection group). The mean and median serum neopterin as well as urine neopterin values differed significantly between the two groups (p <0.01). The first appearance of clinical signs or symptoms of CMV infections was always associated with a marked increase of both serum and urine neopterin values. These increases heralded the positive CMV serology in the mean by 2 weeks. In CMV diseases urine neopterin steadily increased to values above 1000 J.lmol/mol creatinine whereas remained between 500 and 1000 J.lffiol/mol creatinine in cases of CMV infections. A comparable behaviour was shown by the serum neopterin values. In the long-term course patients with CMV diseases developed a broader IgM antibody response than those with CMV infections. In particular the IgM response against the phosphoprotein pp65 and the glycoproteins gB and gH was primarily seen during and after CMV diseases. The anti-viral immune response during CMV infections and diseases is detected by increases of serum and urine neopterin concentrations. The extent of changes in the neopterin values reflect the severity of the clinical illness and permit a distinction between CMV infection and CMV disease. CMV diseases are associated with an IgM antibody response against both tegument and envelope proteins. Immune monitoring with neopte-rin should facilitate clinical decision making, i.e. initiating further diagnostic tests and starting specific anti-viral therapies. Neopterin is produced by human monocytes / macrophages upon stimulation by IFN-y. Therefore, neopterin represents an excellent marker for activation of Th 1 cells and thus, Th I-type immune response. On the other hand, Th2 cells produce interleukins-4, -5, -6, -9, -10 and -13, thereby supporting humoral immune response associated with hyperproduction of immunglobulins, e.g immunglobulin E (lgE). In vitro, neopterin production by human peripheral blood mononuclear cells upon stimulation with the Thl-cytokine IFN-y could be suppressed by typical Th2-cytokines like IL-4 or IL-IO supporting the concept that Th 1 and Th2 cell responses will not occur in parallel but more probably alternatively. In order to examine the relation of the Thl and Th2 cell system in vivo, we studied 709 otherwise healthy outpatients, who visited the physician's office for a medical health check-up. 11% presented \-vi th elevated serum neopterin concentrations (>8.7 nM), 26% had elevated serum IgE concentrations (above 100 mUll). There existed inverse correlations between serum neopterin and 19E concentrations (Spearman's rank correlation coefficient: rs = -0.100; P <0.01) and between serum 19E concentrations and patients' age (r,=-0 .179; p <0.0001). Serum neopterin concentra-tions and patients ' age correlated positively (rs= O. 198; P <0.000 I In humans, Streptococcus pvogenes (group A bhaemolytic streptococci) may cause infections like streptococcal pharyngitis and tonsillitis, toxic scarlet fever and a so called "streptococcal toxic shock-like syndrome" (STSS). These streptococci produce exotoxins like streptococcal erythrogenic toxins A, B or C which have been implicated in the pathogenesis of STSS and scarlet fever by acting as "superantigens": In the presence of antigen-presenting cells bearing MHC class II antigens, they polyclonally stimulate as many as one of ten T cells, triggering an out-of-control production of cytokines like interleukin-(IL)-2, IL-3. IL-6, tumour necrosis factor-a and interferon-y (IFN-y) In contrast to this, common antigens are able to stimulate only one of 10,000 T cells on a clonal level As shown in vitro using human peripheral bloodderived mononuclear cells from healthy individuals. streptococcal erythrogenic toxins induce neopterin production and degradation of the amino acid tryptophan to metabolites like kynurenine. In these experiments it was also demonstrated that neopterin production and tryptophan degradation were mediated by the C)10kine IFN-y and were not due to a direct influence of these toxins on monocy1es I macro-phages. To compare these findings with the in vivo situation, we investigated 7 patients with streptococcal tonsillitis (age, sex) and 4 patients with STSS (age, sex). Those with STSS showed higher serum neopterin concentrations (median:152; range: 71 -242 nM) than those with tonsillitis (median: 12; range: 9 -19 nM). In contrast, concentrations of tryptophan were lower and of kynurenine were higher in patients with STSS (tryptophan : kynurenine) compared to tonsillitis (tryptophan: kynurenine). Likewise the kynurenine per tryptophan ratios were higher in patients with STSS (median: 0.56; range: 0.40 -0.97) compared to tonsillitis (median: 0.04; range: 0.02 -0.05). The data indicate highly increased neopterin production and tryptophan degradation in patients with STSS, but only moderate in those with tonsillitis, thus suggesting an association between higher degree of Tcell activation and the severity of the disease manifestation. This relationship was also obvious in patients during follow-up of treatment. However, the number of patients in this study is certainly to low for a final conclusion and further studies are needed to confirm this conclusion. The reasons for different manifestations of infections caused by streptococcus pyogenes still remain unclear. Different pathogenic potential of different streptococcus pyogenes strains but also different sensitivities of the individuals due to genetic variations of their T cell receptors are a point of discussion.
Formation of oxygen radicals in solutions of
-Dihydroneopterin which is secreted together \\-"ith neopterin by activated macrophages has been shown to be involved in free radical mediated reactions. Initially reduced pterins were reported to be scavengers of free radicals but more recently, it was found that under certain conditions 7.8-dihydro-neopterin promotes hydroxyl radical formation. We investigated ten different 7,8-dihydropterins including 6-( I' -hydroxy)-derivatives, methyl-derivatives and 6-( I ' -oxo )-derivativcs for their ability to stimulate hydroxyl radical formation. For detection of hydroA,),1 radicals hydroxylation of salicvlic acid was used. All but the 6-( I ' -oxo)-deri~atives stimulated hydroxyl radical formation.
The amount of salicylic acid hydroxylation was dependent 011 the stability of the pterin used. In the presence of chelatcd iron ions hydroxylation was invariably increased, even 6-(1 ' -oxo}-derivatives showed a low hydroxylation of salicylic acid. The degree of increase, however, strongly depends on the side chain of the dihydropterin present in the assay and was highest in compounds containing a I' -hydroxy group.
7,8-dihydroneopterin was Investigated in more detail. Iron ions influence both, the stability of the compound and hydroxyl radical formation. While iron ions determine the kinetics of the reaction, 7,8-dihydroneopterin is responsible for the amount of hydroxyl radicals formed. We conclude from our data that promotion of hydroxyl radical formation by 7,8-dihydropterins depends on the oxidizability of the pterin and on iron chelating properties of the compounds. This work was financially supported by the Austrian "Fonds zur Forderung der wissenschaftlichen Forschung", project P12366-CHE. To elucidate the underlying mechanism by which iron regulates IFN-y effector functions, we investi-gated the expression of three IFN-y-inducible genes, namely intercellular adhesion molecule 1 (ICAM-l), HLA-DR, and GTP-cyclohydrolase I (GTP-CH) in human monocytes and in the human monocytic cell line THP-1. IFN-y increased the surface expression of ICAM-l and HLA-DR and stimulated GTP-CH activity as compared to untreated controls. Addition of iron prior to cytokine stimulation resulted in dose-dependent reduction of these pathways, while iron restriction upon desferrioxamine (DFO) treatment enhanced ICAM-I , HLA-DR and GTP-CH expression. The iron induced changes were paralleled by alterations in cytoplasmatic mRNA levels for TCAM-l , HLA-DR and GTP-CH, i. e. reduction of mRNA by iron and increase by DFO in THP-l and in human monocytic cells. Changes in mRNA levels could be referred to altered transcription of IFN-y-inducible target genes. Moreover, ICAM-) expre-ssion, and to a lesser extent, GTP-CH and HLA-DR mRNA, were not only regulated transcriptionally by iron perturbation and IFN-g, but also posttranscriptionally, since iron and IFN-y treatment resulted in shortening of mRNA half-life as compared to cells treated with IFN-y alone. Thus, iron perturbations regulate IFN-y effector pathways by transcriptional and posttranscriptional mechanisms, which indicates that iron may rather repress the IFN-y signal transduction process than directly affecting the expression of these IFN-y-inducible genes. This regulatory network between iron and IFN-y activity is of potential importance for the immune defence against pathogens. New drugs with high iron chelating potential may thus be a future beneficial approach to strengthen immune response mechanisms against intracellular microogranisms. Our preliminary results agree well with the observations reported from Austrian blood transfusion centers. The BRAHMS ELISA test could be easily adapted in our department in Bratislava and gave reliable results. The neopterin concentrations found in our blood donations are similar but appear to be slightly lower than reported from , e.g. Innsbruck, Austria, however, the number of specimens tested so far is to small for a definitive statement. In order to replace the rabbit pyrogen test used for the detection of pyrogenic contaminations in drugs intended for parenteral application, various alternative, mostly cell-based, assays have already been developed (1). Here, three of these cell-based test systems are compared with the limulus amoebocyte lysate (LAL). The LAL test uses amoebo-cytes of the horseshoe crab Limulus polyphemus which aggregate in the presence of endotoxin. The other three tests are based on the measurement of various metabolites (neopterin, nitrite, TNF-a.) synthesized by cultivated human or murine mono-cytoid cell lines. The LAL assay detects endotoxin very sensitively. Endotoxin is a cell wall compound of Gram-negative bacteria and the most important pyrogen. Unfortunately, the LAL test is nearly not able to detect substances of Gram-positive bacteria. The cell-based tests are nearly as sensitive for endotoxin as the LAL assay but the cultivated cells are very potently stimulated by Gram-positive bacterial compounds, especially when filtered but otherwise crude supernatants of S. aureus were added (2) . Within the cell-based assays, a highly significant linear correlation was found between TNF-and neopterin fonnation in the endotoxin-sensitive THP-l I G3 clone stimulated by a panel of 27 bacterial compounds from Gram-positive and Gram-negative bacteria (1 ,3). The non-parametric Speannan rank correlation showed a highly significant correlation of r = 0.5946; P <0.003 (4) . Also the correlation between formation of nitrite and TNF-a. by RAW264.7 cells upon stimulation with various samples yielded, according to the Spearman rank correlation, a highJy significant correlation coefficient of 0.94, p <0.003 (4) . The tested samples included cell wall components from Gram-negative and Gram-positive bacteria, as well as supernatants from S. aureus and a P. aeruginosa culture and DNA purified from S. aureus. Further, a synthetic oligonucleotide identified recently as inducer of septic shock and an inactive control nucleotide (5,6) were tested. At the moment, it can not be clearly decided which of the in vitro methods described here or other available tests, using e.g. whole human blood, is superior. It is, however, clear that such in vitro methods have the potential to reduce or replace the rabbit pyrogen test and also to close the diagnostic gap left by the LAL test. Evaluation of different of these methods, which is currently done, will finally clarify this question.
( Neuroblastoma ranks third in incidence of childhood malignancies and treatment results of stage IV tumours have not improved during the past decades. Interestingly enough disseminated tumours of infancy stage IV S are characterised by spontaneous regression and differentiation towards benign ganglio-neuroma cells. The human neuroblastoma cell line SK-N-SH can serve as a model for differentiation induction studies. The cells are characterised by interconversion between the highly malignant undifferentiated N-type cells via the neuroblastic pathway (markers enzyme tyrosine hydroxylase and metabolites dopamine and norepinephrine) and the well differentiated S-type flat cells via the melanocytic pathway (markers enzyme tyrosinase and substrates phaomelanin and eumelanin). Strong selective inhi-bitors of IMP dehydrogenase, the pacemaker enzyme of GTP and dGTP biosynthesis, such as ribavirin or its modem and more potent analogue tiazofurin (TR, 2-6-Dribofuranosylthiazole-4-carboxarnide) therefore produce an imbalance of deoxynucleotide pools resulting in inhibition of DNA synthesis. By depriving GTP cyclohydrolase, (the key enzyme of the pteridine pathway synthesising tetrahydrobiopterin, the cofactor for tyrosine hydroxylase) from its substrate GTP the important catecholamine pathways in neuroblastoma should be modulated as well. Cytotoxic treatment ofSK-N-SH cells with TR (lOO ~, 2 hr) resulted in GTP depletion to 64 nmoUg cells (39% of PBS treated controls, but a depletion of cellular concentrations of tetrahydrobiopterin (195 pmol/mg protein) and other pterins (biopterin + dihydrobiopterin 9 pmol/mg protein, neopterin 2 pmol/mg protein) could not be achieved. GTP cyclohydrolase has a kM value of 31 ~ for the substrate GTP. 64 ~ GTP content after TR treatment is sufficient to preserve more than half of the maximal enzyme activity, enough to maintain tetrahydrobopterin biosynthesis at a normal level.
Treatment with TR in a differentiating concentrauon over a longer time period (10 1lM. 5 Anaemia is a frequent complication in the course of HIV infection. Lower haemoglobin levels were found to be significantly associated with accelerated progression to AIDS and death. In vitro, HIY is able to infect erythroid progenitor cells. In humans with HIV infection and in monkeys with experimental SIV infection virus could not be detected in isolated progenitor cells. In HIV-I infected patients lower levels of haemoglobin are associated with increased levels of serum and urinary neopterin concentrations. Highly active antiretroviral treatment (HAART) is associated with a decrease in immune activation, including decreased levels of neopterin. The question arises, whether the decrease of immune activation associated with an increase of haemoglobin levels in patients treated with antiretrovirals. To answer tIlis question we evaluated treatment naive patients during the first six months of HAART for the change in levels of urinary neopterin, HIV-I RNA and haemoglobin and for the change in the CD4+ T -lymphocyte count. Patients having received erythropoietin or erythrocyte transfusions were not included in the study. The study population comprised 46 individuals with a mean age of 38.3 ± 9.7 years, 11 were female. Twentytwo of the patients had AIDS. Ten patients were treated with two nucleoside analogues and one non-nucleoside analogue reverse transcriptase inhi-bitor and 36 received antiretroviral combination therapy including protease inhibitors. The mean haemoglobin levels increased from 13 .4 gldL at initiation of therapy to 14 .6 gldL six months later (p <0.001) and median CD4 + T lymphocytes increased from 1001~ to 228/~ (p <0 .001). Median mV-l RNA levels decreased from 5.40 log10 copiesimL to -2.20 10glO copies/mL and urinary neopterin levels decreased from 591 ~moVmol creatinine to 210 ~moVmol creatinine (for both, p<O.OOl) . Haemo-globin levels 6 months after initiation of HAART correlated with baseline urinary neoplerin levels (r. = -0.34, P = 0.02) but not with baseline HIV-1 RNA levels and CD4+ T lymphocytes (r. <0.1, p >0 .2). A correlation was found between the change in haemo-globin levels and the change . in urinary neopterin levels (r. = -0.33, P = 0.03). The change in HIV-l RNA levels and the change in CD4+ T lymphocytes did not correlate with the change in haemoglobin levels (r. <0 .1, p >0.2). However, the percentage of the change of the CD4 + T lymphocytes correlated insignificantly with the change in haemoglobin levels (r, = 0.26, P = 0.08).
Although correlations among pathologies cannot be considered to be equivalent to causation, our data indicate that there is no direct role of HIV in the development of anaemia. The data are consistent with the view that HIV may induce chronic immune stimulation and concomitant release of inhibitory cytokines (e.g. interteron-y and TNF-a.) which in tum are responsible for inhibition of erythropoiesis. In the presence of molecular oxygen and iron ions, differently substituted 7,8-dihydropterins react quite differently with respect to their power of hydroxyl radical generation. We were interested in the electronic properties of such pteridine derivatives and studied therefore the following model compounds: pterin, 7,8-dihydropterin, 5,6, 7, 8-tetrahydropterin, 3,6 ,7, 7-tetra-methyl-7,8-dihydropterin, 6-hydroxy-7,8-dihydropterin and 6-formyl-7.8-dihydropterin. The quantum chemical software program package GAUSSIAN 94 (Gaussian Inc., Carnegie, PA, USA) was used with basis set 6-31 G** after geometry optimisation with basis set 3-21G*. Computed were the total electron density and the electrostatic potential of the molecules. We used a UNIX based version of this software package running on a Silicon Graphics PteridinesNol. IlINo. 1 Workstation Indigo 2 (Silicon Graphics, Vienna, Austria). The properties calculated were visualised using program A VS EXPRESS (Advanced Visual Systems Inc. , Waltham, MA, USA) running on a personal computer. The ab initio quantum chemical computations reveal a dramatic difference in distribution of electronic charge and the electrostatic potential between the aromatic and non-aromatic model compounds. The methyl substitution as well as the hydroxymethyl side chain did not exert a strong influence on the electronic properties of the 7,8-dihydropterin system. In contrast, the substitution with the carbonyl side chain in position 6 shows the expected marked effect upon the electronic distribution; in particular, the vinylogous amide structure of this "carbonyl" group is nicely exhibited This latter functional group causes a particular strong accumulation of negative charge in the region 0 (at C4) -N5 -0 (of side chain). Our results are compatible with recent speculations tha: certain peculiarities of interactions between pteridines and iron-induced radical fonnation may be explainable by complex formation between iron ions and the pteridine derivatives. Presently, we are engaged 1<' establishing experimental evidence for this suspicion This work was financially supported by the Austriar "Fonds zur Forderung der wissenschaftlicher Forschung", prqject P12366-CHE. function of the membrane cholesterol I phospholiplc ratio so that lower ratios are associated with increased membrane fluidity and it also depends on cholestero: concentrations and fatty acid composition C'f phospholipids. Analysing the lipid metabolism both. I n patients with cardiovascular pathology and in rats "ith induced pyridoxal-5-phosphate (P-5-P) defi-ciency, ,, ;; have obtained that changes in lipids mentioned abo\e are observed in P-5-P deficiency. What did these deviations induce in lipids: cofactors which activated or depressed enzyme systems, for example P-5-P, or metabolites, which accumulated as the result of increased metabolites formation and depressed Jts catabolism? For revealing this question the method was elaborated for investigations of phospholipid biosynthesis in vitro. Using this method and liver homogenate from healthy (control) rats we have observed that P-5-P per se does not change the incorporation of fatty acids into phospholipids as well as cholesterol and phospholipid concentrations in samples. Nevertheless, the addition of P-5-P to samples containing liver homogenate from P-5-P deficiency rats with changed cholesterol and phospholipids concentration and fatty acid composition of phospholipids was followed by normalisation of fatty acid incorporation into phospholipids. At present, we have examined the effect of tryptophan, 14 of its metabolites and 9 pteridines on fatty acid incorporation into phospholipids as well as on chole-sterol and phospholipids concentrations in samples. The results allow us to suggest that deviations in the amounts of metabolites can be added to factors regulating lipid metabolism and therefore also membrane fluidity, cell cycle as well as promotion or prevention of atherosclerosis development. This suggestion we would like to discuss with inherited anti phospholipid syndrome and homocysteinaemia accompanied with arterial thrombosis of coronary, brain and other blood vessels. Weight loss is a frequent complication in the course of chronic human immunodeficiency virus (HIV) infection. Chronic immune activation during HIV-I infection, measured by urinary neopterin, was found to be associated with and predictive for the development of wasting syndrom (unintentional weight loss of ~ 10% of body weight). Chronic immune activation and release of cytokines (e.g. interferon-y and TNF-a) seem to be involved in the pathogenesis of progressive weight loss in HIV-l infection. Active antiretroviral therapy in HIV-I infected patients is associated with a decrease of HIV-l RNA, a decrease in immune activation (decrease in neopterin) and an increase of CD4+ T lymphocytes. We were interested to test wether an association exists between the decrease in immune activation during antiretroviral therapy and an increase in body weight. To answer this question, we evaluated patients during the first six months of antiretroviral therapy for the change in urinary neopterin levels. CD4+ T lymphocytes, HIV-l RNA levels and body weight. In the study we included 55 individuals with a mean age of 38,4±9.6 years, 16 were female, 19 were injecting drug users, 18 homosexual men, 16 were infected by heterosexual contacts and 2 were recipients of blood products. 31 of the patients had AIDS. All patients had to be on uninterrupted antiretroviral therapy for ~6 months. Patients were treated with two nucleoside analogues (inhibitors of reverse transcriptase) in combination with either protease inhibitor(s) or a non nucleoside reverse transcriptase inhibitor or both. At start of therapy, patients were treatment naive or had treatment interruption since > 1 year (asymptomatic patients) or >6 months (symptomatic patients). Patients with acute HIV infection and patients with severe ongoing illnesses were excluded of the study. The median body weight increased significantly from 67,5 kg at study entry to 73,1 kg after 6 months of treatment, Body mass index (BMI) increased from 21 , 1 kglm 2 to 23,8 kglm 2 (p<O.OOI). Urinary neo-pterin levels decreased from 731 ~mol/mol creatinine to 214 ~mo1/mol creatinine (p=O,OOl), CD4+ T lymphocytes increased from 81 cells/~ to 220 cellslJ.1L and median HIV-l RNA levels decreased from 5,4 log copies/mL to 2,2 log copieslmL (for both p<O.OOl). There was a strong correlation between the change in body mass index and the change in urinary neopterin levels (rs= -0.44, p=O.OOI). The change in HIV-l RNA levels was correlated with the change in urinary neopterin (r.= 0.31, p=0.02). No correlation was found between the change in HIV-l RNA or the change of CD4+ T lymphocytes with the change in body mass index. In addition, the change of urinary neopterin at month 3 of treatment was strongly correlated with the change of body mass index at month 6 of treatment (r.= -0.44, p=O.OOl). Thus suppression of viral replication by active antiretroviral therapy is associated with a decrease in immune activation and the decrease in immune activation is associated with an increase in body weight. The data suggest that immune activation and endogenous formation of cytokines, responsible for elevation of neopterin concentration (e.g. interferon y) may play an important role in wasting in HIV-l infection. In 1986 neopterin testing was introduced in the Austrian Tyrol as an additional test for the screening of blood donations. In 1994 it became mandatory for all Austrian blood banks as "nonspecific indicator of immune activation to prevent viral transmission by blood donations". Hepatitis C is the most common cause for transfusion transmitted hepatitis. In 1990 hepatitis C antibody screening was implemented in blood transfusion services. It has been estimated that the risk to acquire hepatitis C by blood transfusion was 0.45% before and <0.001% / blood unit after the introduction of this screening. 781 children who needed open heart surgery in Innsbruck and in Munich between 1970 and 1997 were recalled for re-examination.
437 patients followed the invitation. We established 3 patient groups for Innsbruck: operation before 1986 (n= 136), between 1986 and 1990 (n= 59) and after 1990 (n = 122), and 2 groups for Munich: operation before 1990 (n= 38), and after 1990 (n= 64). All patients were tested for hepatitis C antibodies by a commercially available ELISA (Abbott, Delkenheim, Germany). In the Innsbruck groups we found 2 patients to be hepatitis C antibody positive in the group operated before 1986. In the other groups none tested positive. Within the Munich groups we found 6 patients to be hepatitis C positive in the group operated before I 990. There was a signdicant association between number of transfusions and hepatitis C (p = 0.02) and a significant correlation between multiple operation history and hepatitis C (p = 0.02). Associations with neopterin: No hepatitis C transmission between 1986 and 1990 but this result was statistically not significant because of the low number of patients. High number of transfusions before 1986 is a high risk factor for having acquired hepatitis C. Neopterin testing may have been able to reduce the risk. It is important to follow up more and different patient groups who received blood in the time before and after introduction of specific markers to recruit a higher number of polytransfused patients. As there was also another unspecific screening marker (AL T) in use to prevent transfusion transmitted NANB-Hepatitis, the value of neopterin and AL T should be compared. In healthy pregnant women, serum and urine neopterin concentrations are higher than those in nonpregnant female controls of the same age. Because human monocytes / macrophages release large amounts of neopterin on stimulation with interferon-g, these observations indicate activated cellular immunity during pregnancy. At first glance, this seems to contradict the common view that cellular immunity is depressed during pregnancy, as reflected by reduced Tcell and NK-cell activity in vitro . However, in vivo analyses confirm that reduced capacity of cells to respond to antigenic stimulation is often associated with chronic immune stimulation or may even result from it (c.g. patients with HIV infection). From in vitro and in vivo investigations it is well established that interferon-g not only induces formation of neopterin but also activates indoleamine (2,3)-dioxygenase (IDO). Therefore, a significant degradation of tryptophan can be observed when the formation of endogcnous interferon-g is increased.
In an earlier cross-sectional study we compared the serum concentration of neopterin, tryptophan and kynurenine in uncomplicated pregnancy and puerperium. In the actual longitudinal study, plasma was analysed from 20 healthy pregnant women with singelton pregnancies. Heparinised blood samples of these women were taken three times during pregnancy (l6 th to 20 th week, 26 th to 29 th week, 36 th to 39 th week) as well as 6 weeks postpartum. Blood samples were centrifuged immediately after collection and frozen until processing. All measurements were performed in one analytical run. Neopterin was measured by RIA (BRAHMS, Berlin, Germany), tryptophan and kynurenine by HLPC. Group comparisons were made with the Friedman test and the Mann Whitney U-test . Correlations between variables were calculated with the Spearman rank correlation coefficient (rs). Median age of patients was 26 years (range: 19-36), the foetal birth weight was 3405 g (2660-4120), the median week at birth was 41 (36-42). 16 women had a spontaneous labor, four a caesarian section. Neopterin concentrations increased with gestational age (p <0.0(01), the values postpartum showed no significant difference to those of the third trimester. Tryptophan concentrations decreased during pregnancy returning to baseline 6 weeks postpartum (p=0.001). There were significant differences between the first (16 th -20 th week) and second (26 Kynurenine concentrations were significantly increased 6 weeks postpartum, demonstrating highly signi-ficant differences to the values in pregnancy. The kynurenine per tryptophan-(KT)-ratios increased during late pregnancy showing the highest values 6 weeks after birth (p <0.0001). Significant differences were found between the second and the third measurement and between the third measurement and between the third measured and the postpartal values. Patients with spontaneous labour (n = 16) and those with caesarean section (n = 4) showed no significant differences in their postpartum neopterin-and tryptophan-values and their K T -ratios. Neopterin in pregnancy showed a highly significant correlation to the gestational week (rs = 0.56, P <0.001) to kynurenine (rs = 0.32. P <0.05) and to the KT-ratio (rs = 0.44; P <0.001), but not to tryptophan. Tryptophan showed no significant correlation to the gestational week and a significant positive one to kynurenine (rs = 0.50, P <0.001). Kynurenine showed no significant correlation to the gestational week but significant positive correlations to neopterin (r = 0.32, P <0.05). The KT -ratio correlated positively with the gestational week (rs = 0.43, p <0.00l) and with neopterin (rs = 0.44, P <0.001). In our longitudinal study the results of our earlier cross-sectional study could be confimled. There was a significant decrease of tryptophan during gestation and kynurenine values and K T -ratios increased. Thus. low tryptophan concentration during pregnancy are due to degradation of the essential amino acid. Also the highly significant correlation between neopterin and the K T -ratio demonstrates that increased neopterin production is associated with increased tryptophan degradation, both changes caused by activation of specific enzyme by interferon-g. About the cause of the slightly increased neopterin values and the clearly elevated kynurenine values and KT -ratios six weeks postpartum we can only speculate: Possibly these phenomena can be explained by restoration of tissues after pregnancy (e.g. the involution of the enlarged uterus). These processes could lead to prolonged macrophage activation, probably resulting in a decreased functional response to antigenic stimulation. It is known that rubella vaccination in the puerperium only leads to a 85% response compared to a much higher response rate of 95% in routine vaccination in 14-year-old girls at school. Probably due to an alimentary intake tryptophan values postpartum are quite normal leading to no further clinical symptoms like depression, cogrutlve impairment of nocturnal sleep. Also pyridoxal-5-phosphate deficiency could playa role to reduce further conversion of kynurenine in the tryptophan catabolic pathway to nicotinic acid. Further studies are needed to clarify this issue.
The influence of daily psychosocial incidents and associated emotions on the course of biochemical parameters in systemic lupus erythaematosus: experience taken from three "integrative single-case studies" Systemic lupus eIY1haematosus (SLE) is a chronic autoimmune disease characterised by flare-ups, the cause of which is unknown. According to new stress concepts, three "integrative single-case studies" have been conducted in order to gather evidence about whether daily stressful incidents and associated emotions precede or follow a decrease in urine cortisol and an increase in urine neopterin. Patients under study collect their urine at home, for a period of at least 50 days, on a daily basis, divided into day and night urine. Additionally, patients fill out questionnaires twice a day to determine their emotional state, life style and disease activity. Each week, patients were examined clinically and interviewed to identify the past week's stressors using the Incidents and Hassles Inventory (llll, Brown and Harris). Statistical analysis of the serial data is performed using time-series analysis according to Box and Jenkins. In all three "integrative single case studies" we were able to demonstrate that stressful incidents predicted an increase in urine neopterin 36 hours (Case I) to 60 hours (Cases 2 and 3) later (p < 0.05). Furthermore, in Cases 2 and 3 it turned out that stressful incidents led to a decrease in urine cortisol 36 hours later. Additionally, emotional irritation was highly correlated with the course of urine-neopterin. In Case 2 irritation preceded the increase in urine neopterin 84 hours earlier whereas in Case 3 irritation led to an increase in urine neopterin 12 hours later. In conclusion, our results validate the idea of "integrative single-case studies" as a new approach in psychoneuroimmunology.
Neopterin concentrations in blood donors in Lucenec -Slovakia Secnik P, Rakicka I, Gec K General Regional Hospital, Lucenec, Slovakia Neopterin is a non specific marker of the activated immune system. In the course of infections with viruses, e.g. CMV, EBV, Parvovirus B19, intracellular bacteria and with parasites, blood neopterin concentrations are elevated during the acute phase of infections, even before seroconversion. Therefore, neopterin testing in blood donations can help to identifY the infected blood early and to exclude it from further processing. In Austrian blood transfusion centres screening of blood donations is routinely perfonned. The intention of this cooperative study between Lueenec and Bratislava is to investigate the neopterin concentrations in blood donors in a retrospective way. The analytical reliability of the neopterin detennination by ELISA (ELI test screening, BRAHMS, Berlin, Gennany) will be tested, and neopterin concentrations in blood donors from Lueenec will be compared to Bratislava and the published data from Austrian blood donors. Finally, the concentrations of neopterin will be compared to the results of mandatory tests perfonned in parallel. As increased neopterin concentrations are found in the cerebrospinal fluid of patients with, e.g., intrathecal infections, we ested the main brain-resident cell types for their capacity to synthesise neopterin. Primary astrocytes as well as astrocytic cell lines, different neuronal and a microglial cell line were all shown not to be release detectable (> I nmollL) concentrations of neopterin even after stimulation by interferon-y (IFNy) . These results might indicate that infiltrating macrophages are the main neopterin-producing cell type in the brain. Furthermore we examines a possible contribution of biologically active pteridines for the development of inflammatory neurological disorders. Whereas neopterin did not affect the viability of U373 astrocytes, its precursor molecule 7,8-dihydroneopterin induced apoplotic cell death. This effect turned out to be not a direct one but is mediated by a natural occurring degradation product which is not identical with 3 '-hydrox),-sepiapterin. Neither the cytokine tumour necrosis factor (TNF-a.) nor the radical scavenger Nacetyl-cysteine did modulate this 7,8-dihydroneopterininduced effect indicating that radical fonnation may not play a role in the induction of apoptosis. Instead, enhancement of mtnc oxide synthase (iNOS) expression paralleled the induction of cell death by 7,8-dihydroneopterin. The results of our study indicate that derivatives of neopterin might contribute to the generation of brain lesions, thus representing a possible link between inflammation and neurodegeneration. patients with acute inflammations of the CNS showed the expected highly significant and dramatic increase of CSF neopterin (mean 60.45 nmollL, p = 0.008). In comparison with these patients, subjects suffering from idiopathic PO (degeneration of dopaminergic nerve cells in the basal ganglia, especially in substantia nigra, putamen and nucleus caudatus) or idiopathic PO with dementia showed no increase of neopterin neither in serum nor in CSF. In patients with atypical PO (degeneration of dopaminergic nerve cells not only in basal ganglia but also in the cerebellum combined with vascular lesions in the brainstem) and PO combined with multi-infarctions, moderately increased CSF neopterin was observed (mean 7.40 nmollL, p = 0 .05; respectively, mean 8.59 nmollL, p = 0.005). Concentrations of IL-6 and TNF -ex. RII showed the same general pattern among all investigated patient groups. Furthermore, we found significant linear correlations between neopterin in serum and CSF (r = 0.308; P = 0.033, Pearson correlation test) and between IL-2R in serum and CSF (r = 0 .464, P = 0.00l) among all studied subjects. Moreover, there were highly signi-ficant correlations between neopterin and IL-6 in serum (r = 0.461, P = 0.001), between neopterin and IL-2R in serum (r = 0.616, P <000 I) and between neopterin and TNF-ex. RII in serum (r = 0 .826, P <0.00(1). Significant linear correlations were also observed between neopterin and IL-6 in CSF (r = 0 .502, P = 0.0003) and between neopterin and TNF-cx. RII in CSF (r = 0.780, P <0.(001). We conclude that determination of neopterin, IL-6 and TNF-cx. RII concentrations especially in CSF effective helps to distinguish between idiopathic PD where no immune activation could be observed, and atypical PO, where vascular components and multiinfarcts are of crucial importance. Our results suggest that in fact the vascular events may be the cause of the moderate degree of immune activation found in these patients.
( The mechanism of stimulation of nitric oxide synthase (NOS) differs in many aspects from that of phenylalanine hydroxylase. NOS shows a much higher affinity for the pterin cofactor. In contrast to phenylalanine hydroxylase, the pterin cofactor is required by NOS in substoichiometric amounts, and no indication for a redox cycling of tetra.hydrobiopterin from the "quinonoid" 6,7 [8H] dihydrobiopterin in NOS has been observed thus far. On the other hand, allosteric actions of tetrahydrobiopterin are well documented, including the stabilisation of the active, dimeric form the the enzyme, as well as increasing the affinity for the substrate L-arginine. We used two classes of tetrahydrobiopterin derivatives to probe the reaction mechanism. One was the 4-amino analogue of tetrahydrobiopterin, which we designed to inhibit potential dihydropteridine reductase-like reactions inside the active NOS dimer. This compound bound the enzyme with high affinity and inhibited the NOS reaction competitively with tetrahydrobiopterin . Since it also conferred the allosteric actions to the enzyme in an extent similar to tetrahydrobiopterin, we concluded that allosteric actions alone are not sufficient to explain the role of tetrahydrobiopterin in the NOS reaction. The other of novel compounds to probe the NOS reaction mechanism we used were N5-substituted tetrahydro-biopterin derivatives. N5-methyl tetrahydrobioptern was found to be a stimulator of NOS, but could not provide a substrate to the dihydropteridine reductase reaction, and inhibited phenylalanine hydroxylase. We concluded from these results that NOS uses a reaction mechanism different to phenylalanine hydroxylase. Our results are compatible with a novel, one electron redox contribution of the pterin cofactor to stimulate the NOS reaction. Recently, substratedependent detection of a tetrahydrobiopterin radical gave a first, direct experiment evidence supporting the hypothesis of a novel, non classical redox contribution of tetrahydrobiopterin in the NOS reaction. Parkinson' s disease (PO) is the most common hypokinetic illness of the basal ganglia and is characterised by a substantial loss of neurons in the substantia nigra. Clinical manifestations are resting tremor, rigidity, akinesia and bradykinesia. The .letiology of PD is still largely unknown although ~ .. (;disposing factors like age and genetic vulnerability are crucially involved in the pathogenesis of the disease. Oxidative stress and the depletion of cellular defence mechanisms are further considered to be associated with the neurodegenerative process. Oxidative stress is closely associated to cellular immune activation since activated macrophages are a potent source of reactive oxygen species. Cellular immune activation is characterised by high IFN-y activity, not only stimulating monocytes/macrophages to produce neopterin but also stimulating the enzyme indoleamine 2,3-dio,., . . ygenase (IDO) to degrade tryptophan in a broad variety of cells including macrophages. With the impact of this enzyme, kynurenine is formed from tryptophan followed by a series of kynurenine metabolites with partly neurotoxic properties. Simultaneous measurement of kynurenine and tryptophan and calculating the ratio allows to estimate the in vivo activity of IDO and of the extent of cellular immune activation. In Huntington' s and Alzheimer's disease, peripheral immune activation was demonstrated by increased serum neopterin concentrations and an increased TFN-g-mediated tryptophan degradation rate. I n this study we measured neopterin concentrations by ELISA (BRAHMS-Diagnostica , Berlin, Germany) as well as tryptophan and kynurenine concentrations by HPLC in serum and cerebrospinal (CSF) of eleven PD patients with dementia (mean age +/-standard deviation 76.8 +/-2.2 years) . Urinary neopterin concentrations as related to simultaneously measured creatinine concentrations were determined by HPLC, too. The serum and urine data were compared to those from an age These data indicate cellular immune activation in patients with PD. Interestingly, immune activation is not only limited to the brain but seems to be even more pronounced in peripheral blood than in CSF. Since tllere is well accepted agreement that states of increased (cellular) immune activation are highly likely to cause oxidative tissue damage one is prone to speculate that chronic immune activation in PD is a major contributing factor for neuronal loss and hence plays a certain role in the pathogenesis of the disease. furthermore, low tryptophan concentrations may provide an explanation for the psychiatric status of Parkinson patients as t e tryptophan concentration influences the availability of serotonin, the lack of which inducing depression and dementia. Increased homocysteine concentrations have been established as an independent risk factor for atherosclerosis and other vascular and cardiovascular disorders. Homocysteine is formed from S-adenosyl methionine being a donor for activated methyl groups via S-adenosyl homocysteine. Homocysteine concentrations in serum are controlled by two alternative enzyme pathways : the first depending on vitamins BI2 and folic acid to recover methionine, the second depending on vitamin B6 forming cystathion and cysteine. In several cross-sectional studies a close inverse association was observed between homocysteine and folic acid and vitamin B 12 , respectively. Increased homocysteine concentrations has been described in Parkinson 's disease (PD). In this pilot study, we compared homocysteine, folic acid, vitamin B1 2 and neopterin concentrations in 11 PD patients (mean ± S.D .: 76.8 ± 2 .2 years). Hoen and Yahr disease activity scores ranged from 3 to 5 (4.09 ± 0 .94). Six patients received a combination therapy of levodopa and a dopamine decarboxylase inhibitor and within this group 3 patients additionally received amantadine sulfate and seleginine. Two received only amantadine sulfate and in 3 patients prescription was temporarily interrupted. The patients had no signs of infection, and no circumscript vascular lesions were detected by computer tomography. Serum was gained after a nocturnal fasting period. Neopterin was measured by ELISA (BRAHMS Diagnostica, Berlin, Germany), folic acid and vitamin BI2 were simulta-neously measured by double-labeled RIA (Chiron Diagnostic Corporation, Boston, MA, USA), and homocysteine was determined by fluorescence polarization immunoassay (Abbott, Vienna, Austria). The median (interquartile range) concentration for homocysteine was 16.9 J.1M (10.5 -19.7; normal range: 5 -15 J1M), for folic acid 10.4 nM (9.5 -11.5; lower limit of normal : 11 nM), for vitamin B12 260 pM (142 -379; lower limit of normal: 185 pM) and for neopterin 6.9 nM (5.5 -20.7). Accordingly, 55% of the patients had increased homocysteine values (p <0 .01 ; Fischer's exact test), and 73% of the patients had decreased folic acid concentrations (p <0 .001). Four patients had increased neopterin concentrations compared to normals. Administration of levodopa, amantadine sulfate, seleginine or dopamine receptor agonists had no influence on homocysteine concentrations. A significant correlation was found between homocysteine and neopterin concentrations (rs = 0 .591 ; P <0.05) and there was a weak inverse association between homocysteine and folic acid concentrations (rs = -0.499; P = 0.059) which was however not significant at the 5% level. These data provide evidence that increased homocysteine concentrations are related to immune system activation in Parkinson's disease. Measurement of neopterin concentrations allows to estimate the extent of oxidative stress in patients. Thus, a direct relation between oxidative stress and high homo-cysteine concentrations becomes reliable. Oxidative stress, well described in Parkinson' s disease, is also believed to contribute to vascular diseases. Therefore. the data support the view that homocysteine might play a role in the development of vascular lesions concomitant with inflammatory disorders. However, a correlation between neopterin and homocysteine does not necessarily reflect a causal relationship and the number of investigated subjects is rather low. Also the availability of tetrahydrofolic acid as an antioxidant may be hampered by increased levels of oxidants in PO which may contribute to the consumption of the necessary cofactor for the conversion of homocysteine to methionine and may thus underlie hyper-homocysteinaemia. In parallel, total folic acid concentrations may not necessarily reflect the concentration of biologically active tetrahydrofolic acid, which may explain the only weak correlation between homocysteine and total folic acid concen-trations. Taken together, the associations found in our study could provide the basis for an extended knowledge about the metabolic abnormality of the methionine metabolism as is connected to vascular diseases. An High concentrations of proinflammatory cytokines has been found in serum and lung alveoli in patients at risk for and with ARDS. In the majority of studies interleukin-lll (IL-Ill), interleukin-6 (IL-6), and interleukin-8 (lL-8) were elevated in bronchoalveolar lavage fluid (HALF) of ARDS patients. Elevated levels of neopterin in serum and BALF in several lung diseases, e.g . sarcoidosis and interstitial lung disease (lLD), have been reported. Pneumonia was associated with significantly elevated neopterin levels in BALF compared to controls, chronic obstructive pulmonary disease, and ILD. Neopterin in supernatant of cultured alveolar macrophages from patients with ILD was significantly higher than in controls. Recently there is evidence that neopterin has biological activity, since neopterin and 7,8-dihydroneopterin induced apoptosis in the rat alveolar epithelial cell line L2 and neopterin induced expression of intracellular adhesion molecule-l in type II-like alveolar epithelial cells. The aim of our study was to determine if neopterin could be detected in BALF of patients with ALI and ARDS and to determine the relation of neopterin to proinflammatory cytokines in BALF and serum. Nineteen patients (age 18-70), 14 with ARDS and 5 with ALI, were included. ARDS/ALI resulted from major surgery, multiple trauma, thorax trauma, pancreatitis, pneumonia, and sepsis. Bronchoalveolar lavage (100 ml of 0.9% saline solution sequentially instilled and suctioned in 20 ml portions) was performed in the right middle lobe. Neopterin, tumor necrosis factor-a. (TNF-a,) , fL-6, IL-8 were measured in BALF and serum, additionally quantitative microbiologic culture and differential cell count of BALF were performed. Statistical analyses for comparison of BALF and serum concentrations of neopterin and cytokines between patients with ARDS and ALI, and ARDS with negative and poSitIve quantitative microbiological culture (ARDS-/ARDS+) MannWhitney U test was used. Correlations between neopterin and C}10kine levels in BALF, and correlations between neopterin or cytokines and leukocyte count in BALF and Pa02IFi02 were assessed with the Spearman rank correlation. Results are expressed as mean and standard deviation (SD). Neopterin could be detected in BALF lARDS : 4.7 oM (3.5), ALI: 4.5 nM (4.7)] and serum fARDS : 26 .2 oM (29.6), ALI: 18.5 fu1V1 (10.6)], but was not significantly different between the two groups. There was also no difference of neopterin levels in BALF and serum in patient with ARDS with negative and positive microbiological culture of BALF. When using the urea dilution method for estimating the epithelial lining fluid (ELF) of the lavaged lung segment, neopterin concentrations were significantly higher in ELF [ARDS: 140 oM (121), ALI: 125.4 oM (114)] than in serum (ARDS: p<O.OOI , ALl: P = 0.02). In ARDS patients there was only a significant difference of neopterin levels in ELF and serum in patients with negative microbiological culture due to higher serum ncopterin in patients with positive microbiological culture. Neopterin levels in BALF correlated with level of TNF-a. (r = 0 .71 , P = 0.01), fL-6 (r = 0.73 , P = 0 .009), IL-8 (r = 0.57, P = 0.039), and polymorpho-nuclear leukocyte (PMN) count (r = 0 .72, P = 0 .009) in BALF. TNF-a was detectable in low concentrations in BALF in ARDS and ALI patients, levels were significantly higher in patients with ARDS and positive microbiological culture. IL-6 was found in high concentrations in BALF and serum of patients with ARDS and ALI, but was not different between both groups. In ARDS IL-6 was significantly higher in serum of patients with positive microbiological culture [ARDS-: 184.5 pglml (121), ARDS+ : 660 pglml (450). P = 0 .02].
IL-6 in BALF correlated with IL-8 and PMN count in BALF, in serum there was a negative correlation to Pa02IFi02 (r = -0 .6 1, P = 0.0276) . IL-8 levels were significantly higher in patients with ARDS [ARDS : 2679 pglml (1969), ALI: 502 pglml (611), p = 0.01]. and in ARDS patients IL-8 was higher in patients with positive microbiological culture. There was a high correlation between fL-8 and PMN count in BALF (r = 0.9, P = 0 .001) and a negative correlation with the oxygenation-ratio. In summary. neopterin was detectable in BALF of patients with ARDS and ALI. Neopterin concentrations in epithelial linging fluid of lung alveoli are significantly higher than in serum. Neopterin levels in BALF correlate with TNF-a.. IL-6, IL-8 and PMN count in BALF of patients with ARDS and could therefore express the pro-inflammatory cytokine response.
Molecular cloning and functional expression of dibydropteridine reductase from Phvsarum poivcephalum Wild C. Golderer G, Grooner P, Werner-Felmayer G,
WernerER
Institute for Medical Chemistry and Biochemistry, University of Innsbruck. I nllsbruck, Austria Dihydropteridine reductase (DHPR) is an enzyme required for recycling of tetrahydrobiopterin in aromatic amino acid hydroxylation, i.e. in phenylalanine-4-monooxygenase, tyrosine-3-mono-oxygenase and tryptophan-5-monooxygenase. The tetrahydrobiopterin cofactor leaves these reactions as 4a-hydroxy derivative, which after dehydratation yields the S<Xalled "quinonoid" 6,7 [8H] dihydro-biopterin. DHPR recycles this 6,7 [8H] dihydro-biopterin to 5,6,7,8 tetrahydrobioptcrin at the expense ofNADH. During our efforts to clone nitric oxide synthase from Phvsarum po/vcephaJum, we stumbled upon a PCR product with a deduced reading frame homologous to rat and human DHPR Homogenates of Phvsarum cultures showed DHPR activity. Screening of a Phvsarum cDNA library and rapid amplification of cDNA ends (RACE) yielded a cDNA with an open reading frame homologous to rat and human DHPR, with comparable size and isoelectric point. Moreover, 9 of the 11 residues knOWll to cause an abberant form of hyperphenylalaninemia in humans due to DHPR deficiency are conserved in Physarum DHPR Also the short chain dehydrogenase motif(G{21x}YxxxK) is conserved. Functional expression of the clone was achieved using a pET 16b vector in E. coli, and enzymatic activity in isopropyl-I-thio-6-D-galactopyranosid (IPTG)-treated cultures demonstrated by monitoring tetrahydropterin-{fependent consumption of NADH in presence of peroxidase/l-h02.
Our data show iliat Physarum polycephalum contains DHPR activity. We have cloned a eDNA homologous to rat and hwnan DHPR which when expressed in Fcoli exhibits enzymatic activity.
Effects of neopterin derivatives on peripheral blood-derived T -lymphocytes Wirleitner R Mayr C, Spottl N, Baier-Bitterlich G, FuchsD
Institute for Medical Chemistry and Biochemistry, Leopold-Franzens University, and Ludwig Boltzmann Institute for AIDS Research, Innsbruck, Austria Activated cell-mediated immunity, associated e.g. with human immunodeficiency virus infection is accompanied by elevated concentrations of neopterin and 7,8-dihydroneopterin. Recent data report a proapoptotic effect of neopterin-derivatives on various cell types, including human myelomonocytoma cells, T -lymphoblastic cell lines and a human neuronal cell line. Based on these findings we investigated the effect of neopterinderivatives on freshly isolated human T cells. Tlymphocytes were isolated from whole blood obtained from healthy blood donors. After stimulation. cellular nuclei were stained with propidium iodide and analysed on a F ACS-Scan. We found that isolated human T -lymphocytes are sensitive to 7,8-dihydroneopterin-induced apoptosis. Aftt;r 24 hours incubation with I roM 7,8-dihydroneopterin, a 4.8-fold induction of apoptotic cell death was observed compared to unstimulated control cells. When incubated with 5 roM 7,8-dihydroneopterin, T cell showed a 4.4-fold induction of apoptosis after 6 hours, and a 5.4-fold induction after 24 hours stimulation. Whereas coincubation of T cells with 5 roM 7.8-dihydroneopterin and INF-y (lOOU/ml) had no additional effect on the amount of apoptotic cells detected, TNF-a. (50U/ml) was able to super-induce 7,8-dihydroneopterin mediated apoptosis after 6 hours incubation (7 .2-fold induction compared to 5.4-fold with 7,8-dihydroneopterin alone). Interestingly, the oxidized pteridine neopterin had no effect on apoptotic cell death in these experiments. Simul-taneously, the ability of isolated T -lymphocytes to enter the G21M phase of the cell cycle was deter-mined. After 24 hours incubation with I mM 7,8-dihydroneopterin, a significant elevation of cells with double DNA-content was detected (2.2-fold compared to control cells) which increased when cells were incubated with 5 roM 7.8-dihydroneopterin (3 .S-fold). In further experiments, cells were co-incubated with known Pteridines/Vol. lilNo. I stimulators of T cell proliferation, phytohaemagglutinin (PHA) or concanavalin A (ConA). When treated with PHA or ConA (10 ng/ml) alone, a 3-fold or 3.5-fold increase in cells with double DNAcontent, respectively, was detected after 24 hours stimulation, but both lectins had no significant additional effect in co incubations with 7,8-dihydroneopterin (5 mM) . Taken together, we found that 7,S-dihydroneopterin is able to induce apoptosis in resting human T cells isolated from healthy blood donors. The proinflammatory cytokine TNF-a. might have an impact on 7,8-dihydroneopterin-mediated cell death in these cells. Besides this effect. 7,8-dihydroneopterin was found to enable resting T cells to enter the G21M phase of the cell cycle. In the following experiments we want to investigate, jf 7,8-dihydroneopterin itself is able to activate resting T cells, therefore also a possible induction of cytokine production by T cell will be tested.
On tbe baematopietic activities of some pteridines The haematopoietic acivities of some pteridines and their fractions were tested in vitro and in vitvo in different experimental conditions (1-7) . Atsev and Hadjioloff (1) isolated from the chromatophores of amphibian <Rill:!a ridibunda) skin the first ptcridine fraction -ranopterin influencing the process of cell proliferation and differentiation in bone marrow and other haematopoietic organs. Pteridines fractions, Pt-6-COOH and neopterin, isolated from the same dermal chromatophores were tested in vitro and in vivo: the results obtained demonstrated their haemato-poietic and bone marrow stromal cells-proliferative activities (2-7). In mouse bone marrow agar cultures, the data show a well expressed macrophageal-granulocyte colony stimulating activity (MG-CSA) of the exogenously added ranopterin fraction Pt-6-COOH at doses 25 -50 mg/mJ culture medium (2, 3) . It has been proposed that exogenously added Pt-6-COOH penetrates through the cellular and nuclear membranes of the early bone marrow progenitors from the macrophage-granulocytic series and its haematopoietic effects are similar to the ones of haematopoielic growth factors (2, 3) -probably through the nuclear transcription factor-ill (7). In our previous studies (4) we also established the presence of MG-CSA in the super-natants from mouse long-term bone marrow cultures exogenously treated with two ranopterin fractions -Pt-6-COOH and neopterin. In the stromal layers of the neopterin-treated long-term mouse bone marrow cultures one could see haematopoietic islets among stimulated stromal cells (a part of which are typical dendritic cellsDCs), with considerably enhanced adhesiveness on the plastics, which has been interpreted as a sign of mouse bone marrow stromal cell activation and very suitable for producing better blood cell differentiation (5) . The activation of bone marrow stromal cells and especially of the so-called dendritic cells under in vitro influence of exogenously added neopterin was also examined and has been interpreted by us (E. Zvetkova, D . Fuchs, et at, 1999, unpublished data) in relation to the possibility of neopterin, acting in vitro as a bone marrow stem cell factor, to influence of conunon haematopoietic and stromal cell early progenitors (common granulocyte/macrophageal-, eosinophil-, mcgacaryo-cytc-and stromal/dendritic cell progenitors)-activating simultaneously bone marrow haemato-poietic and stromal cell functions -in normal and pathological (6) 
